Published: January 15, 2026 at 2:47 pm
Oxford Biomedica has confirmed it has received an unsolicited takeover approach from private equity giant EQT, sending shares up by more than 15% to 928p today.
The life sciences group is now valued at around £1.13 billion, with its share price up 131.88% over the past year.
In a statement to the market, the MedTech said it is in preliminary discussions with EQT over a possible cash offer for the entire issued and to be issued share capital of the company.
However, it added that there is no certainty a firm offer will be made, or on what terms, and advised shareholders to take no action at this stage.